BINH ĐINH PHARMACEUTICAL AND MEDICAL EQUIPMENT JOINT STOCK COMPANY

Binh Dinh Pharmaceutical and Medical Equipment JSC (Bidiphar): A Legacy Manufacturer with Strong Regional Reach

Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Công ty Cổ phần Dược – Trang thiết bị Y tế Bình Định), widely known as Bidiphar, is a long established name in Vietnam’s pharmaceutical landscape. Founded in 1979 and officially restructured as a joint stock company in the early 2000s, Bidiphar operates under business ID 4100259231, with its head office located in Quy Nhon City, Binh Dinh Province. The company is publicly listed on the Ho Chi Minh Stock Exchange (HOSE) under the ticker symbol DBD.

Bidiphar is legally structured as a joint stock company with a diversified ownership base that includes both institutional and public shareholders. The executive leadership is composed of seasoned industry professionals, led by key figures such as the Chairman of the Board and the General Director (names vary slightly depending on the latest filings). The company maintains several manufacturing facilities certified to GMP-WHO standards, focusing on the production of antibiotics, injectable drugs, functional foods, and medical devices. Its reach extends beyond the domestic market through licensing agreements and export activities to more than 15 countries.

In fiscal year 2023, Bidiphar posted total revenue of USD 67.86 million and a net profit of USD 11.05 million, showing solid performance in a competitive segment. The company reported total assets of USD 122.01 million and owner’s equity of USD 104.38 million, reflecting a conservative and well-capitalized structure. Its moderate growth is supported by consistent reinvestment in technological upgrades and expansion of R&D efforts. Notably, Bidiphar’s working capital structure allows for long-term financial sustainability and supply chain resilience.

Bidiphar plays a crucial role in supplying pharmaceuticals to public hospitals and regional healthcare systems in Central and Southern Vietnam. It is also actively involved in clinical trial support, public procurement projects, and capacity-building partnerships with health authorities. The company’s export orientation, particularly toward African and ASEAN markets, makes it one of Vietnam’s most internationally engaged pharmaceutical manufacturers.

Why This Company Matters in Vietnam Healthcare Economy

BINH ĐINH PHARMACEUTICAL AND MEDICAL EQUIPMENT JOINT STOCK COMPANY matters because it illustrates how Vietnam healthcare system is supported by domestic industrial capacity. Companies like BIDIPHAR reduce systemic dependence on imported finished medicines and help stabilize supply during periods of disruption.

VNBIS Insight and Access to the Full Report

This overview is designed to educate readers about BINH ĐINH PHARMACEUTICAL AND MEDICAL EQUIPMENT JOINT STOCK COMPANY, the structure of Vietnam pharmaceutical industry, and healthcare demand dynamics in Southeast Asia, while intentionally leaving out deeper layers such as product level margins, regulatory approvals, tender exposure, and supply chain concentration.

How to Get the Full Report on VNBIS

1. Visit www.vnbis.com

2. Use the search bar on the website

3. Enter the company name BINH ĐINH PHARMACEUTICAL AND MEDICAL EQUIPMENT JOINT STOCK COMPANY or Business ID 4100259564

4. Open the company profile and select the report you need

THE FULL REPORT IS AVAILABLE AT www.vnbis.com

If you need support interpreting the report for investment analysis, credit risk assessment, or healthcare sector evaluation, VNBIS also provides direct analyst assistance.

BOOK A COMPLIMENTARY CONSULTATION AT
https://vnbis.com/contact/